Poland, Jan. 2 -- Poland based Abbvie Sp. z o.o. has secured contract from Centrum Onkologii im. Franciszka Lukaszczyka w Bydgoszczy for Antineoplastic agents - Delivery of the medicinal product - MIRVETUXIMAB SORAVTANSINE. The value of the contract is worth 583333000 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....